Cardiovascular Risk Factors and Incident Alzheimer Disease: A Systematic Review of the Literature
Open accessThe DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The purpose of this study was to conduct a systematic review of the literature of cardiovascular factors pertaining to incident Alzheimer disease (AD). METHODS: A systematic literature review was conducted of all studies of cardiovascular risk factors for incident AD listed in PubMed in English from 2000 to 2007. Risk factors included hypertension, diabetes, exercise, alcohol intake, smoking, B complex vitamins, homocysteine, stroke, atrial fibrillation, apolipoprotein E (APOE), lipids, and diet. Inclusion criteria consisted of diagnoses of incident AD and longitudinal studies with cohorts of 500 or more. RESULTS: Individual clinically defined risk factors such as hypertension and diabetes were not significantly associated with increased risk for AD. The strength of the association for hypertension could be considerably strengthened by changing criteria such as midlife measurements or using higher cutoffs for systolic blood pressure. APOE epsilon4 was the most consistent risk factor. Interactions between risk factors modify risk particularly for hypertension and diabetes. Interactions modifying risk were also found for exercise and physical function, APOE epsilon4, diabetes, and cholesterol. CONCLUSIONS: In this review, the evidence that single clinically defined cardiovascular risk factors are significantly associated with incident AD is inconsistent at best. The strength of the association of cardiovascular risk factors and AD can be influenced greatly by changing the parameters of measurement of risk factors and by identifying interactions between the factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Risk factors such as hypertension, diabetes, high cholesterol and high homocysteine have been independently linked to an increased risk of Alzheimer’s disease although the evidence remains inconsistent.74–76”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [76]
In the citing paper
“However, two systematic reviews found inconsistent results [37, 42].”
From Alcohol use and dementia: a systematic scoping review (2019) · cites this paper as [42]
In the citing paper
“Furthermore, interactions between alcohol and other risk factors, particularly tobacco smoking, may also exist but these interactions were not assessed [42].”
From Alcohol use and dementia: a systematic scoping review (2019) · cites this paper as [42]
Citations
Cites
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 1×
“9 nmol/L increased risk,(51) whereas another from the Framingham study reported that low serum folate levels did not affect risk.(52) The third paper from WHICAP found that high levels of total folate intake (Z487.”
BackgroundAn active and socially integrated lifestyle in late life might protect against dementia
Fratiglioni, L., Paillard-Borg, S., & Winblad, B. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00767-7 · Cited by 2,135
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888 · cited 1×
“It may be similar to the somewhat controversial reported synergistic effects of several components of the metabolic syndrome such as insulin resistance, obesity and hypertension on cardiovascular risk.(69) One common pathway proposed for this cluster effect is microvascular dysfunction.”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 1×
“A paper from the CAIDE study reported an interaction between high midlife serum cholesterol greater than or equal to 251mg/dL and high midlife systolic blood pressure (Z160mm Hg) that significantly increased risk.(47) Two articles, from the CAIDE and ACT studies, reported no interaction between total cholesterol and A…”
BackgroundPhysical activity and risk of cognitive impairment and dementia in elderly persons
Laurin, D., Verreault, R., Lindsay, J., MacPherson, K., & Rockwood, K. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.498 · Cited by 1,561 · cited 4×
“Males with high level of physical activity had no significant change in risk.(57) A paper from the Cardiovascular Health Cognition Study (CHCS) reported an interaction between leisure-time energy expenditure/activity index and APOE e4.”
BackgroundInfluentialLarson, E. B., Wang, L., Bowen, J. D., McCormick, W. C., Teri, L., Crane, P., & Kukull, W. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-2-200601170-00004 · Cited by 1,463 · cited 5×
“Although exercise was reported to have no effect in 2 of 5 reports, a very intriguing interaction was reported by Larson et al.55 In their study on the effects of exercise on the risk for dementia and AD, they also directly measured performance based physical function.”
BackgroundInfluentialObesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · cited 1×
“One article from the CAIDE study reported that high total cholesterol levels greater than 251mg/dL increased risk significantly.(22) An additional paper from this study also looked at high midlife cholesterol effects and reported that a high midlife total cholesterol of greater than or equal to 251mg/dL increased risk…”
BackgroundLindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261 · cited 3×
“Four of these reported that it did not increase risk.(20,23,32,54) One of these papers from WHICAP, however, found that when stroke was combined with either hypertension or heart disease, the interactions significantly increased risk.”
BackgroundDiabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258 · cited 1×
“Only 1 paper from the Religious Orders Study reported that diabetes increased risk.(39) A paper from the Kungsholmen Project reported that borderline diabetes increased risk,(33) whereas an article from HHP/HAAS found that type 2 diabetes increased risk(40) (Table 2).”
BackgroundType 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135
Mediterranean diet and risk for Alzheimer's disease
Scarmeas, N., Stern, Y., Tang, M., Mayeux, R., & Luchsinger, J. A. (2006) · Annals of Neurology · doi:10.1002/ana.20854 · Cited by 1,103 · cited 1×
“Four papers, all from different studies, reported that alcohol intake had no significant effect on risk.(8,10,59,60) An article from the IndianapolisIbadan study looked at regular alcohol consumption in an African American population and reported a decreased risk for AD.”
BackgroundMidlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008 · cited 1×
“A paper from the Honolulu Heart Program/Honolulu-Asia Aging Study (HHP/HAAS) reported that low midlife diastolic blood pressure (below 80mm Hg) increased risk.(31) These 2 papers from different studies reported inconsistent findings regarding midlife borderline high and midlife high diastolic blood pressure(21,31) (Ta…”
BackgroundMeta-analysis Spurious precision? Meta-analysis of observational studies
Egger, M., Schneider, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7125.140 · Cited by 997 · cited 1×
“We chose to present a systematic review of all literature so that possible sources of heterogeneity could be examined instead of focusing on a statistical combination of data.(6) In presenting the results, we combined all effect estimates into 1 column without specifically noting whether they were HR, RR, or OR estima…”
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790 · cited 2×
“A second paper from WHICAP reported an interaction between diabetes and hypertension.(28) Two articles from the Kungsholmen Project also reported interactions between borderline diabetes and severe systolic hypertension (Z180mm Hg)(33) and diabetes and severe systolic hypertension that increased risk significantly.”
BackgroundHyperinsulinemia and risk of Alzheimer disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · cited 1×
“Additionally, 1 paper from WHICAP reported on the related disorder of hyperinsulinemia and found that increasing insulin levels significantly increased risk.(41) Two papers, one from a study done in Kuopio, Finland and another from the HHP/HAAS, reporting on metabolic syndrome were inconsistent.”
BackgroundDiabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort
Luchsinger, J. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.7.635 · Cited by 682
Podewils, L. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi092 · Cited by 675 · cited 3×
“A paper from the Cardiovascular Health Cognition Study (CHCS) reported an interaction between leisure-time energy expenditure/activity index and APOE e4.(58) Those without APOE e4 had a decreased risk whereas those with APOE e4 had no significant change in risk(58) (Table 3).”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Iivonen, S., Mannermaa, A., Tuomilehto, J., Nissinen, A., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00006 · Cited by 645 · cited 4×
“An additional paper from this study also looked at high midlife cholesterol effects and reported that a high midlife total cholesterol of greater than or equal to 251mg/dL increased risk significantly.(21) Alternatively, an article from WHICAP reported that a total cholesterol of greater than or equal to 229.”
BackgroundInfluentialAlcohol consumption and risk of dementia: the Rotterdam Study
Ruitenberg, A., van Swieten, J. C., Witteman, J. C., Mehta, K. M., van Duijn, C. M., Hofman, A., & Breteler, M. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07493-7 · Cited by 551 · cited 1×
“Four papers, all from different studies, reported that alcohol intake had no significant effect on risk.(8,10,59,60) An article from the IndianapolisIbadan study looked at regular alcohol consumption in an African American population and reported a decreased risk for AD.”
BackgroundFruit and Vegetable Juices and Alzheimer’s Disease: The Kame Project
Dai, Q., Borenstein, A. R., Wu, Y., Jackson, J. C., & Larson, E. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.045 · Cited by 529 · cited 1×
“Four papers, all from different studies, reported that alcohol intake had no significant effect on risk.(8,10,59,60) An article from the IndianapolisIbadan study looked at regular alcohol consumption in an African American population and reported a decreased risk for AD.”
BackgroundDietary Fats and the Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Aggarwal, N., Schneider, J., & Wilson, R. S. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.194 · Cited by 529
Homocysteine and folate as risk factors for dementia and Alzheimer disease
Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E., & Licastro, F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.636 · Cited by 500
Jewell, N. P. (2003) · Chapman & Hall/CRC eBooks · doi:10.1201/9781482286014 · Cited by 496
Caloric Intake and the Risk of Alzheimer Disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2002) · Archives of Neurology · doi:10.1001/archneur.59.8.1258 · Cited by 472
Cognitive activity and incident AD in a population-based sample of older persons
Wilson, R. S., Bennett, D. A., Bienias, J. L., Aggarwal, N. T., Mendes de Leon, C. F., Morris, M. C., Schneider, J. A., & Evans, D. A. (2002) · Neurology · doi:10.1212/01.wnl.0000036905.59156.a1 · Cited by 456 · cited 1×
“Two articles from the CHAP and ACT studies reported that physical activity had no effect on AD risk.(55,56) The article from the ACT study also reported that the interaction between exercise and a low performance-based physical function score decreased risk.”
BackgroundKalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., Ross, G. W., Havlik, R. J., & Launer, L. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2255 · Cited by 417 · cited 1×
“Two papers, one from a study done in Kuopio, Finland and another from the HHP/HAAS, reporting on metabolic syndrome were inconsistent.(42,43)”
MethodAntioxidant Vitamin Intake and Risk of Alzheimer Disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.203 · Cited by 414
Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study
Xu, W. L., Qiu, C. X., Wahlin, A., Winblad, B., & Fratiglioni, L. (2004) · Neurology · doi:10.1212/01.wnl.0000140291.86406.d1 · Cited by 407 · cited 3×
“Two additional papers from the Kungsholmen Project reported that the interaction between severe systolic hypertension (Z180mm Hg) and borderline diabetes or diabetes both significantly increased risk.(33,34) Three articles from 3 separate studies, the Kame Project, the Kungsholmen Project, and the CAIDE study, reporte…”
BackgroundRelation of Plasma Lipids to Alzheimer Disease and Vascular Dementia
Reitz, C., Tang, M.-X., Luchsinger, J., & Mayeux, R. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.705 · Cited by 397 · cited 1×
“01mg/dL decreased risk.(46) Five articles from 4 studies reported on the affect interactions between cholesterol and other risk factors have on risk for AD.”
BackgroundBenefits of fatty fish on dementia risk are stronger for those without APOE ε4
Huang, T. L., Zandi, P. P., Tucker, K. L., Fitzpatrick, A. L., Kuller, L. H., Fried, L. P., Burke, G. L., & Carlson, M. C. (2005) · Neurology · doi:10.1212/01.wnl.0000183148.34197.2e · Cited by 384
Evans, D. A., Bennett, D. A., Wilson, R. S., Bienias, J. L., Morris, M. C., Scherr, P. A., Hebert, L. E., Aggarwal, N., Beckett, L. A., Joglekar, R., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.185 · Cited by 370 · cited 1×
“An article from the Indianapolis-Ibadan Project reported that APOE e4 in African Americans increased the risk significantly,(66) whereas an article from a study done in Chicago, Illinois reported that ApoE e4 had no affect.(67) Three articles from 2 studies looked at APOE e2 in 3 different populations.”
BackgroundAlcohol Intake and Risk of Dementia
Luchsinger, J. A., Tang, M., Siddiqui, M., Shea, S., & Mayeux, R. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52159.x · Cited by 345 · cited 2×
“Furthermore, this study found that light to moderate intake of wine only decreased the risk in ApoE e4 noncarriers.(61)”
BackgroundStroke and the Risk of Alzheimer Disease
Honig, L. S., Tang, M.-X., Albert, S., Costa, R., Luchsinger, J., Manly, J., Stern, Y., & Mayeux, R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1707 · Cited by 343 · cited 4×
“Four of these reported that it did not increase risk.(20,23,32,54) One of these papers from WHICAP, however, found that when stroke was combined with either hypertension or heart disease, the interactions significantly increased risk.”
BackgroundInfluentialThe relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function
Posner, H. B., Tang, M.-X., Luchsinger, J., Lantigua, R., Stern, Y., & Mayeux, R. (2002) · Neurology · doi:10.1212/wnl.58.8.1175 · Cited by 329
Diet and risk of dementia: Does fat matter?: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2002) · Neurology · doi:10.1212/01.wnl.0000038345.77753.46 · Cited by 324
Cardiovascular disease and Alzheimer's disease: common links
STAMPFER, M. J. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01687.x · Cited by 324 · cited 1×
“The apparent association between cardiovascular risk and incident AD may be through the cerebrovascular pathway rather than a direct effect on AD pathology.(68) The biologic explanation for the interactive effects of hypertension and diabetes on AD risk is unclear.”
BackgroundThe NIH Cognitive and Emotional Health Project: Report of the Critical Evaluation Study Committee
Hendrie, H. C., Albert, M. S., Butters, M. A., Gao, S., Knopman, D. S., Launer, L. J., Yaffe, K., Cuthbert, B. N., Edwards, E., & Wagster, M. V. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.11.004 · Cited by 323 · cited 1×
“Risk factors might logically differ across different cognitive outcomes because different cognitive outcomes may emanate from different pathophysiologic processes.(2) This concern appears to be supported by the work of Bennett who have reported that many risk factors that has been identified using other clinical outco…”
ResultSelf-citationMacKnight, C., Rockwood, K., Awalt, E., & McDowell, I. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000064928 · Cited by 313
Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-Based Study
Laitinen, M. H., Ngandu, T., Rovio, S., Helkala, E.-L., Uusitalo, U., Viitanen, M., Nissinen, A., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000093478 · Cited by 298
Association of metabolic syndrome with Alzheimer disease: A population-based study
Vanhanen, M., Koivisto, K., Moilanen, L., Helkala, E. L., Hänninen, T., Soininen, H., Kervinen, K., Kesäniemi, Y. A., Laakso, M., & Kuusisto, J. (2006) · Neurology · doi:10.1212/01.wnl.0000234037.91185.99 · Cited by 295
Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study
Hayden, K. M., Zandi, P. P., Lyketsos, C. G., Khachaturian, A. S., Bastian, L. A., Charoonruk, G., Tschanz, J. T., Norton, M. C., Pieper, C. F., Munger, R. G., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213814.43047.86 · Cited by 293 · cited 2×
“Three papers from the Cache County, National Health and Nutrition Examination Survey I Epidemiologic Followup Study (NHEFS), and Adult Changes in Thought (ACT) studies reported that high cholesterol had no affect.(20,44,45) One article from the CAIDE study reported that high total cholesterol levels greater than 251mg…”
BackgroundLow Blood Pressure and Risk of Dementia in the Kungsholmen Project: A 6-Year Follow-up Study
Qiu, C., von Strauss, E., Fastbom, J., Winblad, B., & Fratiglioni, L. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.223 · Cited by 291 · cited 1×
“The first article reported that a systolic blood pressure equal to or greater than 160mm Hg did not affect risk significantly,(29) whereas the second reported that a systolic blood pressure greater than 180mm Hg significantly increased risk.(30) Additionally, the first paper reported that a low diastolic blood pressur…”
BackgroundDiabetes Mellitus and Risk of Developing Alzheimer Disease: Results From the Framingham Study
Akomolafe, A., Beiser, A., Meigs, J. B., Au, R., Green, R. C., Farrer, L. A., Wolf, P. A., & Seshadri, S. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1551 · Cited by 282
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada
Tyas, S. L., Manfreda, J., Strain, L. A., & Montgomery, P. R. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.3.590 · Cited by 272
Relation of Higher Folate Intake to Lower Risk of Alzheimer Disease in the Elderly
Luchsinger, J. A., Tang, M.-X., Miller, J., Green, R., & Mayeux, R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.86 · Cited by 237 · cited 1×
“9mg) significantly decreased risk.(53) All 3 articles reported that vitamins B6 and B12 had no effect on risk.”
BackgroundMicrovascular Dysfunction: A Potential Pathophysiological Role in the Metabolic Syndrome
Serné, E. H., de Jongh, R. T., Eringa, E. C., IJzerman, R. G., & Stehouwer, C. D. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089680 · Cited by 236
Laurin, D. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh124 · Cited by 231
The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease
Xu, W., Qiu, C., Winblad, B., & Fratiglioni, L. (2007) · Diabetes · doi:10.2337/db06-0879 · Cited by 218 · cited 1×
“Two additional papers from the Kungsholmen Project reported that the interaction between severe systolic hypertension (Z180mm Hg) and borderline diabetes or diabetes both significantly increased risk.(33,34) Three articles from 3 separate studies, the Kame Project, the Kungsholmen Project, and the CAIDE study, reporte…”
BackgroundMorris, M. C., Scherr, P. A., Hebert, L. E., Glynn, R. J., Bennett, D. A., & Evans, D. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1640 · Cited by 217 · cited 1×
“An article from the East Boston Established Populations for Epidemiologic Studies of the Elderly reporting systolic blood pressure and diastolic blood pressure at various years before and after AD diagnosis was inconclusive.(24) Seven papers from 4 studies reported on the effect various interactions have on the risk f…”
BackgroundDietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline
Morris, M. C. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.025858 · Cited by 196
Hsiung, G.-Y. R. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031789 · Cited by 164
Serum cholesterol and risk of Alzheimer disease: A community-based cohort study
Li, G., Shofer, J. B., Kukull, W. A., Peskind, E. R., Tsuang, D. W., Breitner, J. C. S., McCormick, W., Bowen, J. D., Teri, L., Schellenberg, G. D., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000178989.87072.11 · Cited by 159 · cited 2×
“Three papers from the Cache County, National Health and Nutrition Examination Survey I Epidemiologic Followup Study (NHEFS), and Adult Changes in Thought (ACT) studies reported that high cholesterol had no affect.(20,44,45) One article from the CAIDE study reported that high total cholesterol levels greater than 251mg…”
BackgroundDevelopmental and vascular risk factors for Alzheimer's disease
Borenstein, A. R., Wu, Y., Mortimer, J. A., Schellenberg, G. D., McCormick, W. C., Bowen, J. D., McCurry, S. M., & Larson, E. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.04.010 · Cited by 142 · cited 3×
“The fifth article from the Kame Project reported that a history of transient ischemic attack in an APOE e4 noncarrier also increased risk.(35)”
BackgroundAPOE ε4 is not associated with Alzheimer's disease in elderly Nigerians
Gureje, O., Ogunniyi, A., Baiyewu, O., Price, B., Unverzagt, F. W., Evans, R. M., Smith‐Gamble, V., Lane, K. A., Gao, S., Hall, K. S., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20694 · Cited by 139
Self-citationCholesterol, APOE genotype, and Alzheimer disease: An epidemiologic study of Nigerian Yoruba
Hall, K., Murrell, J., Ogunniyi, A., Deeg, M., Baiyewu, O., Gao, S., Gureje, O., Dickens, J., Evans, R., Smith-Gamble, V., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000194507.39504.17 · Cited by 128 · cited 1×
“A fifth paper from the Indianapolis-Ibadan study reported that increasing levels of cholesterol in an APOE e4 noncarrier increased risk in African Americans, whereas in those with APOE e4 there was no affect.(48) Purnell et al Alzheimer Dis Assoc Disord Volume 23, Number 1, January–March 2009”
BackgroundSelf-citationA 2‐year follow‐up study of cigarette smoking and risk of dementia
Juan, D., Zhou, D. H. D., Li, J., Wang, J. Y. J., Gao, C., & Chen, M. (2004) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00779.x · Cited by 118 · cited 1×
“Three studies, the Chicago Health and Aging Project (CHAP), WHICAP, and a study from Chongqing City, reported that current smoking increased the risk of incident AD.(28,49,50) An additional article from the Canadian Study of Health and Aging (CSHA) recorded only smoking and found that it was not significant.”
BackgroundAggarwal, N. T., Bienias, J. L., Bennett, D. A., Wilson, R. S., Morris, M. C., Schneider, J. A., Shah, R. C., & Evans, D. A. (2006) · Neuroepidemiology · doi:10.1159/000091654 · Cited by 118 · cited 1×
“Three studies, the Chicago Health and Aging Project (CHAP), WHICAP, and a study from Chongqing City, reported that current smoking increased the risk of incident AD.(28,49,50) An additional article from the Canadian Study of Health and Aging (CSHA) recorded only smoking and found that it was not significant.”
BackgroundQiu, C. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.021493 · Cited by 110 · cited 1×
“The third paper from the Kungsholmen Project reported that APOE e2 also did not affect risk in a Swedish population except in females between the ages of 75 and 84.(64) In this segment of the population, the presence of APOE e2 decreased risk significantly.”
BackgroundAssociation of Apolipoprotein E Genotype and Alzheimer Disease in African Americans
Murrell, J. R., Price, B., Lane, K. A., Baiyewu, O., Gureje, O., Ogunniyi, A., Unverzagt, F. W., Smith-Gamble, V., Gao, S., Hendrie, H. C., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.431 · Cited by 108
Self-citationCardiovascular risk factors and cognitive function
Grodstein, F. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.01.001 · Cited by 105 · cited 1×
“The most consistent finding in these prior reviews is the association of cognitive impairment with cardiovascular disease.(4) It has been suggested that researchers focusing on different cognitive outcomes may identify a different set of risk factors (or place different weights on known risk factors).”
BackgroundCombined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD
Qiu, C., Winblad, B., Fastbom, J., & Fratiglioni, L. (2003) · Neurology · doi:10.1212/wnl.61.5.655 · Cited by 84 · cited 3×
“The article from the Kungsholmen Project also reported no significant interaction between systolic blood pressure of greater than or equal to 140mm Hg and antihypertensive drug use or between a systolic blood pressure of greater than or equal to 140mm Hg, APOE e4, and antihypertensive drug use.(29) Regarding diastolic…”
BackgroundRectal Diazepam Gel for Treatment of Acute Repetitive Seizures in Adults
Cereghino, J. J. (2002) · Archives of Neurology · doi:10.1001/archneur.59.12.1915 · Cited by 81
Incidence and Risk Factors of Dementia in a Defined Elderly Japanese Population: The Hisayama Study
FUJISHIMA, M., & KIYOHARA, Y. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04793.x · Cited by 67
Mainous, A. G., Eschenbach, S. L., Wells, B. J., Everett, C. J., & Gill, J. M. (2005) · PubMed · Cited by 55
Risk factors for incident Alzheimer's disease in African Americans and Yoruba
Ogunniyi, A. O., Hall, K. S., Gureje, O., Baiyewu, O., Gao, S., Unverzagt, F. W., Smith‐Gamble, V., Evans, R. M., Dickens, J., Musick, B. S., et al. (2006) · Metabolic Brain Disease · doi:10.1007/s11011-006-9017-2 · Cited by 52 · cited 2×
“The authors indicated that selfreport of hypertension was unreliable in this population because of their limited access to healthcare.(25)”
BackgroundSelf-citationZandi, P. P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.82 · Cited by 47
Risk factors and early signs of Alzheimer's disease in a family study sample: Risk of AD
Heun, R., Kölsch, H., & Jessen, F. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0596-4 · Cited by 45
Bennett, D. A. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200607001-00009 · Cited by 44 · cited 1×
“This concern appears to be supported by the work of Bennett who have reported that many risk factors that has been identified using other clinical outcomes become nonsignificant when AD pathology is used as the outcome.(5) At the last Alzheimer Association conference on prevention, a symposium on potential primary pre…”
BackgroundLowering the risk of Alzheimer's disease: Evidence‐based practices emerge from new research
Jedrziewski, M. K., Lee, V. M.-Y., & Trojanowski, J. Q. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.09.007 · Cited by 39 · cited 1×
“This conclusion is at variance with other recent reviews of the association between risk factors and cognitive outcomes that reported a more consistent association(2,3) but these incorporated broader outcomes, cognitive decline,(2) or a mix of AD, dementia, and cognitive decline.(3) It is possible that these outcomes…”
ResultCerebrovascular disease, APOEϵ4 allele and cognitive decline in a cognitively normal population
Qiu, C., Winblad, B. G., & Fratiglioni, L. (2006) · Neurological Research · doi:10.1179/016164106x130443 · Cited by 21
Postmortem Indices Linking Risk Factors to Cognition
Bennett, D. P. (2006) · Alzheimer Disease & Associated Disorders · Cited by 4
Cited by
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“Furthermore, AD and cerebrovascular diseases may have common risk factors, such as hypertension, insulin resistance, diabetes, obesity, hyperhomocystinemia, hyperlipidemia, etc. (Craft, 2009; Fillit et al., 2008; Honjo et al., 2012; Purnell et al., 2009).”
Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement
Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., Blazer, D. G., Chen, C., Chui, H., et al. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000034 · Cited by 852
Cardiovascular Risk Factors Promote Brain Hypoperfusion Leading to Cognitive Decline and Dementia
de la Torre, J. C. (2012) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2012/367516 · Cited by 440
“These conditions are reported to contribute to cognitive dysfunction and decline affecting performance in executive functions, attention, learning, psychomotor speed, verbal fluency, mental alertness, and memory [51–60] (Figure 2).”
BackgroundAlcohol use and dementia: a systematic scoping review
Rehm, J., Hasan, O. S. M., Black, S. E., Shield, K. D., & Schwarzinger, M. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0453-0 · Cited by 450
Metadata
- Authors
- Purnell, C., Gao, S., Callahan, C. M., & Hendrie, H. C.
- Affiliations
- Regenstrief Institute (US)
- Corresponding author
- Purnell, Christianna
- Callahan, Christopher M.
- Hendrie, Hugh C.
- Venue
- Alzheimer Disease & Associated Disorders
- Published
- 2009-01
- Volume
- 23
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0893-0341 (ISSN-L)
- PMC
- PMC3689425
- OpenAlex
- W2048918162
- Cited by
- 189
- References
- 73
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8 · 2023: 5 · 2022: 10 · 2021: 7 · 2020: 9 · 2019: 10 · 2018: 10 · 2017: 13 · 2016: 6 · 2015: 12 · 2014: 19 · 2013: 9 · 2012: 14
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Alzheimer Disease & Associated Disorders (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- National Institute on Aging (P30AG010133, K24AG024078, P30AG024967, P30 AG-10133, R01AG009956)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- Alzheimer's disease, cardiovascular risk factors, hypertension, diabetes mellitus, physical activity, alcohol consumption, smoking, homocysteine, stroke, atrial fibrillation, APOE ε4, lipids, diet, risk factor interactions
- MeSH terms
- Alzheimer Disease, Cardiovascular Diseases, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.